Cellectis S.A. (EPA: ALCLS)
France
· Delayed Price · Currency is EUR
1.804
-0.064 (-3.43%)
Dec 3, 2024, 1:57 PM CET
Cellectis Employees
As of December 31, 2023, Cellectis had 221 total employees, including 216 full-time and 5 part-time employees. The number of employees decreased by 16 or -6.75% compared to the previous year.
Employees
221
Change (1Y)
-16
Growth (1Y)
-6.75%
Revenue / Employee
€147,558
Profits / Employee
€345,858
Market Cap
186.98M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
EssilorLuxottica Société anonyme | 151,292 |
Ipsen S.A. | 5,325 |
Eurofins Scientific SE | 61,798 |
MedinCell S.A. | 134 |
ABIVAX Société Anonyme | 61 |
Eurobio Scientific Société anonyme | 300 |
Inventiva S.A. | 123 |
Cegedim SA | 6,582 |
Cellectis News
- 27 days ago - Cellectis Presents Multiple Strategies to Enhance CAR T-cell Efficacy in Solid Tumors at the SITC Annual Meeting - GlobeNewsWire
- 27 days ago - Cellectis S.A. (CLLS) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Cellectis Provides Business Updates and Financial Results for Third Quarter 2024 - GlobeNewsWire
- 4 weeks ago - What To Expect From Cellectis SA (CLLS) Q3 2024 Earnings - GuruFocus
- 4 weeks ago - Cellectis to Report Third Quarter 2024 Financial Results on November 4, 2024 - GlobeNewsWire
- 6 weeks ago - Cellectis to Present Data on TALE-Base Editors and Non-Viral Gene Therapy at the ESGCT 31st Annual Congress - GlobeNewsWire
- 3 months ago - Cellectis Presents Pre-Clinical Evidence of MUC1 CAR T-cells Reducing Triple-Negative Breast Cancer While Preserving Safety - GlobeNewsWire
- 3 months ago - Cellectis: Cheap With Promising But Speculative Cancer Therapies - Seeking Alpha